Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase
M. Deichmann
*
,
B. Kahle
, K. Moser, J. Wacker, K. Wüst
*
Corresponding author for this work
Clinic of Dermatology, Allergology and Venerology
Ruprecht-Karls Universität Heidelberg
58
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Cancer Staging
100%
C Reactive Protein
100%
Melanoma
100%
Stage 2 Cancer
22%
Stage 3 Cancer
22%
Stage 1 Cancer
22%
Prospective Study
11%
Logistic Regression Analysis
11%
Metastatic Melanoma
11%
Acute Phase Protein
11%
Rank Sum Test
11%
Agricultural and Biological Sciences
Committees
100%
Americans
100%
Lactate Dehydrogenase
100%
Acute Phase Protein
11%
Keyphrases
American Joint Committee on Cancer
100%
Cancer Stage
100%
Stage IV Melanoma
22%
ROC-AUC
22%
AUC Value
11%
Serum Markers
11%
Acute Phase Proteins
11%
Median Value
11%
Mann-Whitney Test
11%
Curve ROC
11%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Cancer Staging
100%
Cutaneous Melanoma
11%
Immunology and Microbiology
C-Reactive Protein
100%
Cancer Staging
100%
Acute Phase Protein
11%